Jpmorgan Chase & CO Essa Pharma Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Essa Pharma Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 21 shares of EPIX stock, worth $34. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 21
-0.0%
Holding current value
$34
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EPIX
# of Institutions
35Shares Held
35.1MCall Options Held
15.8KPut Options Held
21K-
Bvf Inc San Francisco, CA8.75MShares$14.3 Million1.69% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.88MShares$12.9 Million0.8% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.29MShares$7.03 Million2.21% of portfolio
-
Morgan Stanley New York, NY4.18MShares$6.86 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.35 Million0.32% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $72.3M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...